Table 1

Treatment aims and strategies

Response rate (%)
QuestionRheumatologists (n=870)Other (n=131)
(A) Treatment aims of rheumatologists
 Clinical remission (measured using a composite index)67.942.7
 Patient satisfaction with response54.742.0
 No structural progression54.433.6
 No functional deterioration46.729.8
 Prevention of disability42.638.2
 Low disease activity (measured using a composite score)34.927.5
 Good clinical response by my own judgment34.827.5
 70% Improvement of clinical activity30.822.1
 50% Improvement of clinical activity21.024.4
 Moderate disease activity (measured using a composite index)8.513.0
 Any type of response7.113.0
 20% Improvement of clinical activity5.58.4
 Do not know0.56.1
(B) Assessment of treatment success
 Percentage improvement or absolute improvement by continuous disease activity indices (eg, DAS28, SDAI)67.645.8
 I judge the presence of a clinical state (eg, high or low disease activity)59.151.1
 Traditional ACR response criteria34.741.2
 Do not know0.56.9
(C) Reasons for the modification of treatment
 Persistently high disease activity76.458.8
 Significant radiographic progression (irrespective of clinical state)63.849.6
 Patient-reported difficulties with daily activities52.058.0
 Persistently moderate disease activity49.829.8
 Patient dissatisfaction with response48.940.5
 Not reaching remission42.323.7
 Do not know0.77.6
  • Indicated are the percentages of respondents to each question, separately for rheumatologists and non-rheumatologists.

  • ACR, American College of Rheumatology; DAS28, 28 joint count Disease Activity Score; SDAI, Simplified Disease Activity Index.